The global CRRT market is estimated to grow at a CAGR of 7.2% from 2015 to 2020. Although mature markets such as the U.S., Germany, and the U.K. held larger shares in the CRRT market in 2015, Asia-Pacific is poised to grow at the highest CAGR of 8.7% in the next five years. Factors such as increasing aging population, rise in sepsis cases, growing focus of multinational companies on emerging markets, improvements in and the modernization of healthcare infrastructure, and high incidences of AKI cases in this region are propelling the growth of this market.

The overall growth of the CRRT market is driven by factors such as the rising prevalence of AKI, increasing prevalence of sepsis, growing number of ICU patients, rapid rise in aging population, clinical advantages of CRRT over intermittent blood purification techniques, and the preference for CRRT (it is held as a gold standard for the treatment of hemo dynamically unstable patients). However, factors such as high complexity of therapy, high procedural cost of CRRT, stringent regulatory guidelines for CRRT in North America, and the dearth of trained ICU nurses are restraining the growth of this market. Moreover, emerging markets(such as China, India, Brazil, and Mexico);broadening application horizons of CRRT, ongoing researches to establish the safety and efficacy profile of CRRT, and the development of a CRRT system for pediatric patients are creating opportunities for the players involved in the market.

In this report, the global CRRT market has been segmented on the basis of product [CRRT systems, CRRT disposables ( hemofilters, bloodlines, and other disposables), and dialysate and replacement fluids] and modality [slow continuous ultra filtration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemo dialysis (CVVHD), and continuous venovenous hemo diafiltration (CVVHDF)].

Geographically, Europe (comprising Germany, France, the U.K., and Rest of Europe) commanded the largest share of41% of the global CRRT market in 2015, followed by North America. The European CRRT market is primarily driven by various factors such as the increasing cases of AKI in this region and rising aging population, approvals for CRRT machines and anti-coagulating agents in Europe for multiple applications, high utilization rate of CRRT products in Europe, prescription of CRRT products by intensivists in Europe, and research studies and controlled clinical trials to obtain efficacy and safety profile of CRRT products. However, the inconsistent reimbursement scenario for CRRT procedure across European countries is one of the major factors restraining the growth of the CRRT market in this region.

The global CRRT market is highly consolidated in nature. Baxter International Inc. (U.S.) dominated the global CRRT market, with a share of ~55% in 2014, followed by Fresenius Medical Care AG & Co. KGaA (Germany). Other players include Asahi Kasei Medical Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l. (Italy), Infomed SA (Switzerland), Medica S.p.A (Italy), Medical Components, Inc. (U.S.), Nikkiso Co., Ltd (Japan), NxStage Medical, Inc. (U.S.), and Toray Medical Company Limited (Japan).Product approvals, launches, and enhancements; acquisition; and geographical expansion are the major strategies adopted by market players to achieve growth in theCRRT market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis such as industry analysis (industry trends and Porter’s five forces model), market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the CRRT market, high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on CRRT products offered by the top 10 players in the CRRT market. The report analyzes the CRRT market byproduct and modality across geographies
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the CRRT market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for CRRT products across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the CRRT market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the CRRT market

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Introduction
2.1.1 Research Methodology Steps
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.2.1.1 Key Data From Secondary Sources
2.1.2.2 Primary Research
2.1.2.2.1 Key Data From Primary Sources
2.1.2.2.2 Key Industry Insights
2.1.2.2.2.1 Supply Side
2.1.2.2.2.2 Demand Side
2.1.3 Market Size Estimation Methodology
2.1.3.1 Estimation of CRRT Procedural Volume
2.1.3.2 Research Methodology: Top-Down Approach {For Market Size Estimation of Disposables (Bloodline Sets, Hemofilters, and Water Bags)}
2.1.3.3 Research Methodology: Top-Down Approach (For Market-Size Estimation of CRRT Machines)
2.1.3.4 Research Methodology: Bottom-Up Approach
2.1.4 Research Design
2.1.5 Market Data Validation and Triangulation
2.1.5.1 Data Triangulation Steps (Top-Down and Bottom-Up Approaches)
2.1.6 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Market Potential
4.2 Market Opportunity
4.3 CRRT Market, By Product and Modality (2015 vs 2020)
4.4 CRRT Market, By Modality (2015)
4.5 CRRT Market, By Region (2015)
4.6 CRRT Market, By Country (2015 vs 2020)

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Product
5.2.2 By Modality
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Prevalence of AKI
5.3.1.2 Rising Adoption of CRRT for the Treatment of Renal Disorders
5.3.1.3 Growing Number of ICU Patients
5.3.1.4 Rapid Rise in Aging Population
5.3.1.5 Clinical Advantages of CRRT Over Intermittent Blood Purification Techniques
5.3.1.6 CRRT is A Gold Standard for Treatment of Hemodynamically Unstable Patients
5.3.1.7 Technological Advancements and New Product Launches
5.3.1.8 Increasing Prevalence of Sepsis
5.3.2 Restraints
5.3.2.1 High Complexity of Therapy
5.3.2.1.1 Lack of Standard Treatment Guidelines
5.3.2.1.2 Complications Associated With CRRT
5.3.2.2 High Procedural Cost of CRRT
5.3.2.3 Stringent Regulatory Guidelines for CRRT in North America
5.3.2.4 Dearth of Trained ICU Nurses
5.3.3 Opportunities
5.3.3.1 Emerging Markets
5.3.3.2 Broadening Application Horizon of CRRT
5.3.3.2.1 Evolution of CRRT From Simple Renal Replacement Treatment to A Multi-Organ Support Therapy (Most)
5.3.3.2.2 CRRT: Progression From Adaptive Renal Devices to Multipurpose Treatment Machines
5.3.3.3 Ongoing Researches to Establish Safety and Efficacy Profile of CRRT
5.3.3.4 Development of A CRRT System for Pediatric Patients
5.3.3.4.1 The Carpediem Project
5.3.3.5 Untapped Market Growth Opportunities in North America
5.3.4 Challenges
5.3.4.1 Poor Reimbursement Scenario in Developing Countries
5.3.4.2 Lack of Substantial Clinical Evidences Supporting Efficacy of CRRT
5.3.4.3 Currently Approved CRRT Technology is Inadequate for Children
5.3.4.4 Lack of Awareness About the Benefits of CRRT
5.3.5 Winning Imperatives
5.3.5.1 Selling Machines Along With Disposables to End Users.
5.3.5.1.1 High Bargaining Margins on Disposables as Well as Machines
5.3.5.1.2 Development of CRRT Machine That is Only Compatible With Respective Company’s Disposables
5.3.5.1.3 Core Competency of Players
5.3.6 Key Industry Trends
5.3.6.1 Training Programs for the Operation of CRRT Devices
5.3.6.2 Rising Adoption of User-Friendly CRRT Machines

6 Industry Insights
6.1 Introduction
6.1.1 Reimbursement Scenario
6.1.1.1 North America
6.1.1.2 Europe
6.1.1.3 Asia-Pacific (Excluding Japan)
6.1.1.4 Japan
6.1.1.5 Rest of the World
6.1.2 Regulatory Landscape
6.1.2.1 North America
6.1.2.2 Europe
6.1.2.3 Asia-Pacific
6.1.2.4 Rest of the World
6.1.3 Porter’s Five Forces Analysis
6.1.3.1 Competitive Intensity
6.1.3.2 Bargaining Power of Buyers
6.1.3.3 Bargaining Power of Suppliers
6.1.3.4 Threat of Substitutes
6.1.3.5 Threat of New Entrants
6.1.4 Pricing and Cost Analysis
6.1.5 Strategic Recommendations
6.1.5.1 Design Recommendations for CRRT Machines
6.1.5.2 Key Strategies for Players Seeking to Enter the CRRT Market

7 Adoption of CRRT, By Region
7.1 Introduction
7.2 Utilization of CRRT Procedures, By Region
7.3 Number of CRRT Patients, By Region

8 CRRT Market, By Product
8.1 Introduction
8.1.1 Dialysate and Replacement Fluids
8.1.2 Disposables
8.1.2.1 Hemofilters
8.1.2.2 Bloodline Sets (Tubing Sets)
8.1.2.3 Other Disposables
8.1.3 CRRT Systems

9 CRRT Market, By Modality
9.1 Introduction
9.1.1 Slow-Continuous Ultrafiltration (SCUF)
9.1.2 Continuous Venovenous Hemofiltration (CVVH)
9.1.3 Continuous Venovenous Hemodialysis (CVVHd)
9.1.4 Continuous Venovenous Hemodiafiltration (CVVHDF)

10 CRRT Market, By Region
10.1 Introduction
10.2 CRRT Market, By Region
10.2.1 Europe
10.2.1.1 CRRT Machines Approved for Multiple Applications
10.2.1.2 Intensivists’ Preference for CRRT for AKI Treatment
10.2.1.3 Players Focus on Leveraging Growth Opportunities in Europe
10.2.1.4 Germany
10.2.1.4.1 Rising Focus of Players on the German CRRT Market
10.2.1.5 U.K.
10.2.1.5.1 Rising Awareness About AKI in U.K.
10.2.1.6 France
10.2.1.6.1 Symposia and Conferences
10.2.1.7 Rest of Europe
10.2.1.7.1 Clinical Research and Trials Driving Market Growth in Roe
10.2.2 North America
10.2.2.1.1 North American Utilization of CRRT Lower Than That of Europe, Australia, and Japan
10.2.2.1.2 Regulatory Policies, A Key Hindrance to Market Growth
10.2.2.2 U.S.
10.2.2.2.1 Prevalence of AKI, Esrd Rising Due to Growth in Aging Population
10.2.2.2.2 Technological Advancement to Boost Demand for CRRT Products
10.2.2.2.3 Ongoing Clinical Trials to Prove Safety and Efficacy of CRRT Products
10.2.2.2.4 Government Funding & Grants to Develop Cost-Effective Treatments for AKI Patients
10.2.2.2.5 Shortage of Registered Nurses in ICU Settings
10.2.2.3 Canada
10.2.2.3.1 Rising AKI Prevalence
10.2.2.3.2 Barriers to Enter the Canadian CRRT Market
10.2.2.3.3 High Costs of CRRT as Compared to IHD
10.2.3 Asia-Pacific
10.2.3.1 High Use of CRRT in Australia and Japan
10.2.3.1.1 Studies and Clinical Trials to Establish the Safety and Efficacy Profile of CRRT
10.2.3.1.2 Dearth of Reimbursement and Technical Expertise
10.2.3.2 Japan
10.2.3.2.1 Japan Focusing on the Use of CRRT for Non-Renal Indications
10.2.3.2.2 Large Number of Domestic Manufacturers—A Barrier to the Entry of Major Players
10.2.3.3 China
10.2.3.3.1 Rising Incident of AKI and Esrd in the China
10.2.3.4 India
10.2.3.4.1 Sepsis is the Major Cause for AKI in India
10.2.3.5 Rest of Asia-Pacific
10.2.3.5.1 High Utilization of CRRT in Australia
10.2.4 Rest of the World (RoW)
10.2.4.1 South Africa
10.2.4.2 Latin America and the Middle East

11 Competitive Intelligence Analysis
11.1 Competitive Intensity
11.1.1 Evaluation Parameters and Scores
11.1.2 Scoring Methodology
11.1.3 Competitive Intensity Score, By Company
11.1.3.1 Baxter
11.1.3.2 Nxstage
11.1.3.3 B. Braun
11.1.3.4 Fresenius
11.1.4 Competitive Intensity - Mapping of Baxter, Nxstage, B.Braun, and Fresenius
11.1.5 Market Share Analysis
11.1.5.1 Baxter International Inc.
11.1.5.2 Fresenius Medical Care Ag & Co. Kgaa
11.1.5.3 Nxstage Medical, Inc.
11.2 Competitive Situation and Trends
11.2.1 Product Approvals, Launches, and Enhancements
11.2.2 Expansions
11.2.3 Acquisitions
11.2.4 Agreements, Partnerships, and Collaborations

12 Company Profiles
12.1 Introduction
12.2 Fresenius Medical Care Ag & Co. Kgaa
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Recent Developments (2012–2015)
12.2.4 MnM View
12.3 Nxstage Medical, Inc.
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Recent Developments (2012–2015)
12.3.4 MnM View
12.4 Baxter International Inc.
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Recent Developments (2012–2015)
12.4.4 MnM View
12.5 B. Braun Melsungen Ag
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Recent Development (2012–2015)
12.5.4 MnM View
12.6 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
12.6.1 Business Overview
12.6.2 Products Offered
12.6.3 Recent Developments (2012–2015)
12.7 Toray Medical Company Limited
12.7.1 Business Overview
12.7.2 Product Offered
12.7.3 Recent Development (2012–2015)
12.8 Nikkiso Co., Ltd.
12.8.1 Business Overview
12.8.2 Products Offered
12.8.3 Recent Development (2012–2015)
12.8.4 MnM View
12.9 Bellco S.R.L.
12.9.1 Business Overview
12.9.2 Products Offered
12.9.3 Recent Developments (2012–2015)
12.10 Medical Components, Inc.
12.10.1 Business Overview
12.10.2 Products Offered
12.11 Infomed Sa
12.11.1 Business Overview
12.11.2 Products Offered
12.11.3 Recent Developments (2012–2015)
12.12 Medica S.P.A
12.12.1 Business Overview
12.12.2 Products Offered
12.12.3 Recent Development (2012–2015)

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports

List of Tables

Table 1 Average Selling Price (ASP) of CRRT Machines, By Manufacturer, 2014
Table 2 Average Selling Price of CRRT Bloodlines and Dialysate Bags, 2014
Table 3 Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 4 CRRT Dialysate & Replacement Fluids Market Size, By Region, 2013-2020 (USD Million)
Table 5 Europe: CRRT Dialysate & Replacement Fluids Market Size, By Country, 2013-2020 (USD Million)
Table 6 North America: Continuous Renal Replacement Therapy Dialysate & Replacement Fluids Market Size, By Country, 2013-2020 (USD Million)
Table 7 Asia-Pacific: CRRT Dialysate & Replacement Fluids Market Size, By Country, 2013-2020 (USD Million)
Table 8 Continuous Renal Replacement Therapy Market Size, By Disposables, 2013-2020 (USD Million)
Table 9 Continuous Renal Replacement Therapy Disposables Market Size, By Region, 2013-2020 (USD Million)
Table 10 Europe: Continuous Renal Replacement Therapy Disposables Market Size, By Country, 2013-2020 (USD Million)
Table 11 North America: CRRT Disposables Market Size, By Country, 2013-2020 (USD Million)
Table 12 Asia-Pacific: CRRT Disposables Market Size, By Country, 2013-2020 (USD Million)
Table 13 Continuous Renal Replacement Therapy Systems Market Size, By Region, 2013-2020 (USD Million)
Table 14 Europe: Continuous Renal Replacement Therapy Systems Market Size, By Country, 2013-2020 (USD Million)
Table 15 North America: Continuous Renal Replacement Therapy Systems Market Size, By Country, 2013-2020 (USD Million)
Table 16 Asia-Pacific: Continuous Renal Replacement Therapy Systems Market Size, By Country, 2013-2020 (USD Million)
Table 17 Continuous Renal Replacement Therapy Market Size, By Modality, 2013-2020 (USD Million)
Table 18 Continuous Renal Replacement Therapy Market Size for SCUF, By Region, 2013-2020 (USD Million)
Table 19 North America: CRRT Market Size for SCUF, By Country, 2013-2020 (USD Million)
Table 20 Europe: Continuous Renal Replacement Therapy Market Size for SCUF, By Country, 2013-2020 (USD Million)
Table 21 Asia-Pacific: CRRT Market Size for SCUF, By Country, 2013-2020 (USD Million)
Table 22 Continuous Renal Replacement Therapy Market Size for CVVH, By Region, 2013-2020 (USD Million)
Table 23 North America: CRRT Market Size for CVVH, By Country, 2013-2020 (USD Million)
Table 24 Europe: CRRT Market Size for CVVH, By Country, 2013-2020 (USD Million)
Table 25 Asia-Pacific: CRRT Market Size for CVVH, By Country, 2013-2020 (USD Million)
Table 26 Continuous Renal Replacement Therapy Market Size for CVVHd, By Region, 2013-2020 (USD Million)
Table 27 North America: CRRT Market Size for CVVHd, By Country, 2013-2020 (USD Million)
Table 28 Europe: CRRT Market Size for CVVHd, By Country, 2013-2020 (USD Million)
Table 29 Asia-Pacific: CRRT Market Size for CVVHd, By Country, 2013-2020 (USD Million)
Table 30 CRRT Market Size for CVVHDF, By Region, 2013-2020 (USD Million)
Table 31 North America: CRRT Market Size for CVVHDF, By Country, 2013-2020 (USD Million)
Table 32 Europe: CRRT Market Size for CVVHDF, By Country, 2013-2020 (USD Million)
Table 33 Asia-Pacific: CRRT Market Size for CVVHDF, By Country, 2013-2020 (USD Million)
Table 34 Continuous Renal Replacement Therapy Market Size, By Region, 2013-2020 (USD Million)
Table 35 Europe: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 36 Europe: Continuous Renal Replacement Therapy Products Market Size, By Country, 2013-2020 (USD Million)
Table 37 Europe: Market Size, By Modality, 2013-2020 (USD Million)
Table 38 Europe: CRRT Market Size, By Country, 2013-2020 (USD Million)
Table 39 Germany: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 40 Germany: CRRT Market Size, By Modality, 2013-2020 (USD Million)
Table 41 U.K.: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 42 U.K.: CRRT Market Size, By Modality, 2013-2020 (USD Million)
Table 43 France: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 44 France: CRRT Market Size, By Modality, 2013-2020 (USD Million)
Table 45 Rest of Europe: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 46 Rest of Europe: CRRT Market Size, By Modality, 2013-2020 (USD Million)
Table 47 North America: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 48 North America: Continuous Renal Replacement Therapy Products Market Size, By Country, 2013-2020 (USD Million)
Table 49 North America: CRRT Market Size, By Modality, 2013-2020 (USD Million)
Table 50 North America: Continuous Renal Replacement Therapy Modalities Market Size, By Country, 2013-2020 (USD Million)
Table 51 U.S.: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 52 U.S.: CRRT Market Size, By Modality, 2013-2020 (USD Million)
Table 53 Canada: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 54 Canada: CRRT Market Size, By Modality, 2013-2020 (USD Million)
Table 55 Asia-Pacific: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 56 Asia-Pacific: CRRT Market Size for Products, By Country, 2013-2020 (USD Million)
Table 57 Asia-Pacific: Market Size, By Modality, 2013-2020 (USD Million)
Table 58 Asia-Pacific: CRRT Modalities Market Size, By Country, 2013-2020 (USD Million)
Table 59 Japan: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 60 Japan: Market Size, By Modality, 2013-2020 (USD Million)
Table 61 China: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 62 China: Continuous Renal Replacement Therapy Market Size, By Modality, 2013-2020 (USD Million)
Table 63 India: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 64 India: Market Size, By Modality, 2013-2020 (USD Million)
Table 65 Rest of Asia-Pacific: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 66 Rest of Asia-Pacific: CRRT Market Size, By Modality, 2013-2020 (USD Million)
Table 67 RoW: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 68 RoW: Market Size, By Modality, 2013-2020 (USD Million)
Table 69 Product Approvals, Launches, and Enhancements, 2012-2015
Table 70 Expansions, 2012-2015
Table 71 Acquisitions, 2012-2015
Table 72 Agreements, Partnerships, and Collaborations, 2012-2015

List of Figures

Figure 1 Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation Methodology
Figure 4 Market Segmentation
Figure 5 Europe to Command the Largest Share of the Overall Continuous Renal Replacement Therapy Market in 2015
Figure 6 Hemofilters to Form the Largest Segment of CRRT Disposables Market in 2015
Figure 7 CVVHDF is Poised to Be the Fastest-Growing Segment in the Next Five Years
Figure 8 Asia-Pacific is Poised to Grow at the Highest Growth Rate in the Forecast Period
Figure 9 Baxter Will Continue to Dominate the Global Continuous Renal Replacement Therapy Market in the Next Five Years
Figure 10 High Potential and Applications of CRRT to Increase Its Share in the High-Margin AKI Market
Figure 11 Market Growth Will Be Driven By the Rising Prevalence of AKI
Figure 12 Dialysate & Replacement Fluids Product Segment and CVVH Modality Segment Will Dominate the Market
Figure 13 CVVH Dominates the Asia-Pacific CRRT Market in 2015
Figure 14 Europe Accounts for the Largest Share of the Overall CRRT Market in 2015
Figure 15 U.S. to Dominate Global CRRT Market in the Next Five Years
Figure 16 Market Segmentation
Figure 17 Market Segmentation, By Product
Figure 18 Market Segmentation, By Modality
Figure 19 Continuous Renal Replacement Therapy Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Continuous Renal Replacement Therapy Market is Expected to Grow Inline With Rising Prevalence of AKI
Figure 21 Rise in Global Adoption of CRRT
Figure 22 Use of CRRT as A Gold Standard for Treatment of Hemodynamically Unstable Patients is Driving Market Growth
Figure 23 High Procedural Cost of CRRT Restraining the Market Growth
Figure 24 Evolution of CRRT From Simple Renal Replacement Treatment to Multipurpose Therapy Unfolds New Growth Opportunities
Figure 25 Lack of Substantial Clinical Evidences Supporting Efficacy of CRRT Poses A Key Challenge for the Market
Figure 26 Key Factors Affecting Reimbursement Rates for CRRT Procedures
Figure 27 Reimbursement Scenario of CRRT in 2015
Figure 28 Reimbursement Structures Vary Widely Across Europe
Figure 29 Key Regulatory Bodies Involved in the Approval of New CRRT Products
Figure 30 Porter’s Five Forces Analysis – Global CRRT Market
Figure 31 Design Recommendations for CRRT Machines
Figure 32 Utilization of CRRT and Dialysis for the Treatment of Renal Patients in ICU, By Region (2014)
Figure 33 Rate of Switching From CRRT to IHD, By Region, 2014
Figure 34 Number of CRRT Patients Across the Globe, 2014
Figure 35 Europe Will Dominate the Overall CRRT Market in the Forecast Period
Figure 36 Disposables Form the Fastest-Growing Business Within the Global CRRT Industry
Figure 37 Hemofilters to Dominate the CRRT Disposables Market in Next Five Years
Figure 38 Types of CRRT Modalities
Figure 39 CVVHDF Segment to Grow at the Highest CAGR in the Forecast Period
Figure 40 Europe to Dominate the Overall CVVH Market for the Next Five Years
Figure 41 Europe is Estimated to Account for the Major Share of the Total CVVHDF Market in 2015
Figure 42 Growth in AKI Cases Worldwide (2010 -2020)
Figure 43 Europe Will Dominate the Overall CRRT Market in the Forecast Period
Figure 44 The U.S. Will Be the Major Contributor to the Global CRRT Market in the Forecast Period
Figure 45 European CRRT Market Snapshot: Germany Will Continue to Dominate the Market in the Forecast Period
Figure 46 Germany to Drive the Growth of CRRT Market in Europe
Figure 47 CVVH Accounted for the Major Share of the European CRRT Market in 2015
Figure 48 North American CRRT Market Snapshot: U.S. Will Be the Major Contributor to Market Growth in the Next Five Years
Figure 49 Asia-Pacific CRRT Market Snapshot: China Will Be the Fastest-Growing Country in the Region
Figure 50 China Will Be the Fastest-Growing Country in the Asia-Pacific CRRT Market in the Forecast Period
Figure 51 Dialysate & Replacement Fluids Segment Accounts for the Major Share of the RoW CRRT Market, By Product, in 2015
Figure 52 Scoring Methodology
Figure 53 Comparison of Competitive Intensity Scores: Baxter, Nxstage, B.Braun, and Fresenius
Figure 54 Relative Positioning of Companies Based on Competitive Intensity Score and CRRT Focus
Figure 55 Global CRRT Products Market Share Analysis, By Key Player, 2014
Figure 56 Geographic Revenue Mix of Top Four Players (2014)
Figure 57 Fresenius Medical Care AG & Co. KGAA: Company Snapshot
Figure 58 Nxstage Medical, Inc.: Company Snapshot
Figure 59 Baxter International Inc.: Company Snapshot
Figure 60 B. Braun Melsungen AG: Company Snapshot
Figure 61 Asahi Kasei Corporation: Company Snapshot
Figure 62 Toray Group: Company Snapshot
Figure 63 Nikkiso Co., Ltd.: Company Snapshot